Vir Biotechnology, Inc. · 8 minutes ago
Senior Specialist, Payroll & Accounts Payable (Temporary)
Vir Biotechnology is a clinical-stage biopharmaceutical company focused on discovering and developing medicines for serious infectious diseases and cancer. They are seeking an experienced Senior Specialist in Payroll and Accounts Payable to manage payroll processing and assist with accounts payable functions while contributing to month-end close activities. The ideal candidate will have hands-on expertise with payroll and accounting systems and a strong understanding of accounting principles.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Fully manage end-to-end payroll processing for the entire company using UKG, ensuring accuracy, compliance, and timely delivery
Serve as the primary point of contact for all payroll-related inquiries during the assignment
Assist the Accounts Payable Supervisor with daily invoice processing, vendor communication, and payment operations using Coupa
Engage in key month-end accounting activities, including account reconciliations, preparation and posting of journal entries, and variance analysis using NetSuite
Support audit requests and assist with internal and external reporting as needed
Maintain the confidentiality and security of sensitive payroll and employee data
Collaborate with Finance, HR, and cross-functional teams to resolve discrepancies and contribute to continuous process improvement
Qualification
Required
5+ years of relevant accounting experience, including payroll administration and accounts payable functions
Proficiency with UKG payroll, Coupa, and NetSuite (required)
Strong knowledge of accounting principles and payroll best practices
Demonstrated experience with month-end close processes, including reconciliations and journal entries
Superior attention to detail, organizational, and communication skills
Ability to adapt and thrive in a fast-paced environment, working both independently and as part of a team
Preferred
Bachelor's degree preferred
Experience in the biotechnology or life sciences sector is a plus
Company
Vir Biotechnology, Inc.
At Vir Biotechnology, Inc., we leverage the immense potential of the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer.
Funding
Current Stage
Public CompanyTotal Funding
$908.6MKey Investors
Biomedical Advanced Research and Development Authority (BARDA)Bill & Melinda Gates FoundationGlaxoSmithKline
2023-10-03Grant· $50M
2023-05-02Grant· $10M
2022-10-04Grant· $55M
Recent News
2025-12-19
MarketScreener
2025-12-17
2025-12-17
Company data provided by crunchbase